Liver Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults who are older than 18 years of age at the time of signing the consent form
• People who have a primary liver tumor (a tumor that started in the liver)
• People who are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

• People who have, or have had, a cancer diagnosis (other than the liver tumor being studied)
• People who have an active autoimmune disease (where the immune system attacks the body) or who are currently being treated with medicines that suppress the immune system
• People who have tested positive for HIV, hepatitis C (HCV), or hepatitis B (HBV)
• People who have diabetes
• People who have other cancers outside the liver that have occurred in the last 3 years — except for cancers that were fully removed with the intent to cure, have shown no signs of returning for more than 3 years before signing the consent form, and are considered low risk of coming back
• People who have chronic autoimmune or inflammatory diseases (long-term conditions where the immune system is overactive)
• People who are currently being treated with specific medicines including atezolizumab, bevacizumab, sorafenib, lenvatinib, regorafenib, cabozantinib, checkpoint inhibitors, tyrosine kinase inhibitors, or anti-VEGF therapies (confirm with trial site if unsure whether a current medication falls into these categories)
• People who have other serious health conditions where life expectancy is less than 12 months
• People who are not willing or able to sign the consent form

Important: Always verify eligibility with the trial site directly before applying.